Childhood immune thrombocytopenia (ITP) is a rare autoimmune bleeding disorder. Most
children recover within 6 to 12 months, but individual course is difficult to predict. We …

Background Immune thrombocytopenia (ITP) during childhood spontaneously remits in up to
80% of children. Predictors of remission are not well understood. Procedure We analyzed …

Long-term follow-up of children with immune thrombocytopenia (ITP) indicates that the
majority undergo remission and severe thrombocytopenia is infrequent. Details regarding …

The decision to treat or only observe the minimally symptomatic child with severe
thrombocytopenia remains controversial. This ongoing debate has served as a mandate to …

Objective: Immune thrombocytopenia (ITP) is a common bleeding disorder in childhood,
characterized by isolated thrombocytopenia. The International Working Group (IWG) on ITP …

Background There is paucity of data on long‐term probability of remission in chronic
idiopathic thrombocytopenic purpura (ITP). Aim was to study the course and factors …

Purpose This study aimed to evaluate the clinical course of childhood immune
thrombocytopenia (ITP) and to assess the risk factors for developing chronic ITP. Methods …

Childhood chronic immune thrombocytopenic purpura (cITP) is a rare disease. In severe
cases, there is no evidence for the optimal therapeutic strategy. Our aim was to describe the …

Background Initial clinical factors that can reliably predict a successful within‐1‐year
resolution of childhood immune thrombocytopenia (ITP) are still unclear. This study aimed to …

Background There is limited information on long‐term follow‐up and prognostic factors for
remission among children diagnosed with chronic immune thrombocytopenia (ITP). The aim …